Boston Scientific Corporation (0HOY.L)
USD 102.19
(0.98%)
USD 102.19
(0.98%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 2.48 Billion USD | 33.05% |
| 2022 | 1.86 Billion USD | 15.96% |
| 2021 | 1.61 Billion USD | 19.17% |
| 2020 | 1.35 Billion USD | -14.44% |
| 2019 | 1.57 Billion USD | 35.42% |
| 2018 | 1.16 Billion USD | 8.16% |
| 2017 | 1.07 Billion USD | 12.88% |
| 2016 | 955 Million USD | -6.0% |
| 2015 | 1.01 Billion USD | 7.4% |
| 2014 | 946 Million USD | 5.46% |
| 2013 | 897 Million USD | 1.47% |
| 2012 | 884 Million USD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 2.56 Billion USD | 3.1% |
| 2024 Q2 | 2.6 Billion USD | 1.84% |
| 2024 Q3 | 2.75 Billion USD | 5.56% |
| 2023 FY | 2.48 Billion USD | 33.05% |
| 2023 Q4 | 2.48 Billion USD | 3.33% |
| 2023 Q2 | 2.25 Billion USD | 9.76% |
| 2023 Q3 | 2.4 Billion USD | 6.84% |
| 2023 Q1 | 2.05 Billion USD | 9.8% |
| 2022 Q4 | 1.86 Billion USD | 4.36% |
| 2022 Q2 | 1.75 Billion USD | 0.92% |
| 2022 Q1 | 1.73 Billion USD | 7.83% |
| 2022 FY | 1.86 Billion USD | 15.96% |
| 2022 Q3 | 1.78 Billion USD | 2.11% |
| 2021 Q2 | 1.43 Billion USD | 1.63% |
| 2021 Q4 | 1.61 Billion USD | 0.44% |
| 2021 FY | 1.61 Billion USD | 19.17% |
| 2021 Q3 | 1.6 Billion USD | 12.1% |
| 2021 Q1 | 1.4 Billion USD | 4.15% |
| 2020 FY | 1.35 Billion USD | -14.44% |
| 2020 Q1 | 1.62 Billion USD | 3.1% |
| 2020 Q2 | 1.51 Billion USD | -6.88% |
| 2020 Q4 | 1.35 Billion USD | -8.22% |
| 2020 Q3 | 1.47 Billion USD | -2.9% |
| 2019 Q3 | 1.56 Billion USD | 20.46% |
| 2019 Q2 | 1.3 Billion USD | 5.86% |
| 2019 FY | 1.57 Billion USD | 35.42% |
| 2019 Q1 | 1.22 Billion USD | 5.32% |
| 2019 Q4 | 1.57 Billion USD | 0.83% |
| 2018 Q2 | 1.08 Billion USD | -2.34% |
| 2018 Q1 | 1.11 Billion USD | 3.25% |
| 2018 FY | 1.16 Billion USD | 8.16% |
| 2018 Q4 | 1.16 Billion USD | 2.82% |
| 2018 Q3 | 1.13 Billion USD | 4.32% |
| 2017 Q4 | 1.07 Billion USD | 0.09% |
| 2017 FY | 1.07 Billion USD | 12.88% |
| 2017 Q2 | 1.02 Billion USD | 5.36% |
| 2017 Q1 | 971 Million USD | 1.68% |
| 2017 Q3 | 1.07 Billion USD | 5.28% |
| 2016 Q1 | 1.02 Billion USD | 0.59% |
| 2016 Q4 | 955 Million USD | -4.31% |
| 2016 Q3 | 998 Million USD | 1.73% |
| 2016 Q2 | 981 Million USD | -4.01% |
| 2016 FY | 955 Million USD | -6.0% |
| 2015 Q2 | 968 Million USD | 1.04% |
| 2015 FY | 1.01 Billion USD | 7.4% |
| 2015 Q4 | 1.01 Billion USD | -6.45% |
| 2015 Q3 | 1.08 Billion USD | 12.19% |
| 2015 Q1 | 958 Million USD | 1.27% |
| 2014 Q2 | 949 Million USD | 2.48% |
| 2014 Q3 | 989 Million USD | 4.21% |
| 2014 Q4 | 946 Million USD | -4.35% |
| 2014 FY | 946 Million USD | 5.46% |
| 2014 Q1 | 926 Million USD | 3.23% |
| 2013 Q2 | 842 Million USD | -1.06% |
| 2013 Q1 | 851 Million USD | -3.73% |
| 2013 FY | 897 Million USD | 1.47% |
| 2013 Q3 | 895 Million USD | 6.29% |
| 2013 Q4 | 897 Million USD | 0.22% |
| 2012 Q4 | 884 Million USD | 0.0% |
| 2012 FY | 884 Million USD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Phreesia, Inc. | - USD | -Infinity% |
| Accuray Incorporated | 138.32 Million USD | -1695.784% |
| Align Technology, Inc. | 296.9 Million USD | -736.64% |
| Elevance Health Inc. | -46.33 Billion USD | 105.361% |
| AxoGen, Inc. | 23.02 Million USD | -10690.617% |
| CVS Health Corporation | 18.02 Billion USD | 86.219% |
| Cardinal Health, Inc. | 14.95 Billion USD | 83.392% |
| Centene Corporation | - USD | -Infinity% |
| DaVita Inc. | 143.1 Million USD | -1635.788% |
| HCA Healthcare, Inc. | 2.02 Billion USD | -22.909% |
| Hologic, Inc. | 679.8 Million USD | -265.402% |
| Humana Inc. | - USD | -Infinity% |
| IDEXX Laboratories, Inc. | 380.28 Million USD | -553.199% |
| Laboratory Corporation of America Holdings | 474.6 Million USD | -423.388% |
| Masimo Corporation | 545 Million USD | -355.78% |
| McKesson Corporation | 21.13 Billion USD | 88.249% |
| Patterson Companies, Inc. | 782.89 Million USD | -217.283% |
| Quest Diagnostics Incorporated | 190 Million USD | -1207.368% |
| ResMed Inc. | 822.25 Million USD | -202.098% |
| Henry Schein, Inc. | 1.81 Billion USD | -36.86% |
| Teladoc Health, Inc. | 29.51 Million USD | -8316.63% |
| Universal Health Services, Inc. | 216.98 Million USD | -1044.764% |
| Veeva Systems Inc. | - USD | -Infinity% |
| Baxter International Inc. | 2.82 Billion USD | 12.04% |
| Becton, Dickinson and Company | 3.27 Billion USD | 24.106% |
| Intuitive Surgical, Inc. | 1.22 Billion USD | -103.506% |
| Danaher Corporation | 2.59 Billion USD | 4.241% |
| Stryker Corporation | 4.84 Billion USD | 48.709% |
| Medtronic plc | 5.21 Billion USD | 52.386% |